221 related articles for article (PubMed ID: 19969409)
1. Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial.
Palacios S; Wildt L; Parke S; Machlitt A; Römer T; Bitzer J
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):57-62. PubMed ID: 19969409
[TBL] [Abstract][Full Text] [Related]
2. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.
Zeun S; Lu M; Uddin A; Zeiler B; Morrison D; Blode H
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):221-32. PubMed ID: 19565420
[TBL] [Abstract][Full Text] [Related]
4. Estradiol valerate/dienogest: a novel combined oral contraceptive.
Borgelt LM; Martell CW
Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.
Jensen JT
Expert Opin Pharmacother; 2010 May; 11(7):1147-57. PubMed ID: 20367275
[TBL] [Abstract][Full Text] [Related]
6. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
Saletu B
Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
von Schoultz B
Climacteric; 2003 Aug; 6 Suppl 2():24-32. PubMed ID: 14669841
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe.
Nelson A; Parke S; Makalova D; Serrani M; Palacios S; Mellinger U
Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):264-73. PubMed ID: 23651474
[TBL] [Abstract][Full Text] [Related]
9. Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.
Endrikat J; Parke S; Trummer D; Schmidt W; Duijkers I; Klipping C
Contraception; 2008 Sep; 78(3):218-25. PubMed ID: 18692612
[TBL] [Abstract][Full Text] [Related]
10. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: results from a clinical study conducted in North America.
Nelson A; Parke S; Mellinger U; Zampaglione E; Schmidt A
J Womens Health (Larchmt); 2014 Mar; 23(3):204-10. PubMed ID: 24279594
[TBL] [Abstract][Full Text] [Related]
12. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
Macìas G; Merki-Feld GS; Parke S; Mellinger U; Serrani M
J Obstet Gynaecol; 2013 Aug; 33(6):591-6. PubMed ID: 23919857
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
Caruso S; Agnello C; Romano M; Cianci S; Lo Presti L; Malandrino C; Cianci A
J Sex Med; 2011 Oct; 8(10):2841-50. PubMed ID: 21810188
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial.
Fraser IS; Römer T; Parke S; Zeun S; Mellinger U; Machlitt A; Jensen JT
Hum Reprod; 2011 Oct; 26(10):2698-708. PubMed ID: 21784734
[TBL] [Abstract][Full Text] [Related]
15. Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland.
Golbs S; Domhardt R; Radowicky S; Kałuzny Z; Wisser KH; Zimmermann T
Methods Find Exp Clin Pharmacol; 2002 Nov; 24(9):585-92. PubMed ID: 12616705
[TBL] [Abstract][Full Text] [Related]
16. Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under.
Jensen JT; Bitzer J; Nappi RE; Ahlers C; Bannemerschult R; Parke S
Eur J Contracept Reprod Health Care; 2020 Apr; 25(2):98-105. PubMed ID: 32162555
[No Abstract] [Full Text] [Related]
17. Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
Jensen JT; Parke S; Mellinger U; Serrani M; Mabey RG
Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):274-83. PubMed ID: 23638631
[TBL] [Abstract][Full Text] [Related]
18. [Association of E2v/DNG as contraceptive choice for a better quality of life of women].
Nappi RE
Minerva Ginecol; 2012 Feb; 64(1):41-52. PubMed ID: 22334230
[TBL] [Abstract][Full Text] [Related]
19. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
[TBL] [Abstract][Full Text] [Related]
20. Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.
De Leo V; Fruzzetti F; Musacchio MC; Scolaro V; Di Sabatino A; Morgante G
Contraception; 2013 Sep; 88(3):364-8. PubMed ID: 23769016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
